Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
6
Bearish filings
35
Named actors
9
Disclosed $ (bull / bear)
$1K / $977K
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-05 | Vice President, R&DSS Enguent Jean-Pierre | sold | $37K | SEC ↗ |
| 2026-08-03 | Vice President, R&DSS Enguent Jean-Pierre | exercised options & held the shares | $150 | SEC ↗ |
| 2026-07-08 | Vice President, R&DSS Enguent Jean-Pierre | sold | $42K | SEC ↗ |
| 2026-06-05 | Chief Executive Officer Moreira Carlos | sold | $1K | SEC ↗ |
| 2026-06-05 | Chief Financial Officer O'Hara John Charles | sold | $502 | SEC ↗ |
16 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-06-03 | Chief Executive Officer Moreira Carlos | sold | $25K | SEC ↗ |
| 2026-06-03 | Chief Financial Officer O'Hara John Charles | sold | $20K | SEC ↗ |
| 2026-06-03 | Vice President, R&DSS Enguent Jean-Pierre | sold | $53K | SEC ↗ |
| 2026-06-02 | Chief Executive Officer Moreira Carlos | sold | $37K | SEC ↗ |
| 2026-06-02 | Chief Financial Officer O'Hara John Charles | sold | $37K | SEC ↗ |
| 2026-05-29 | Chief Executive Officer Moreira Carlos | sold | $35K | SEC ↗ |
| 2026-05-29 | Chief Financial Officer O'Hara John Charles | sold | $35K | SEC ↗ |
| 2026-05-27 | Chief Executive Officer Moreira Carlos | sold | $15K | SEC ↗ |
| 2026-05-27 | Chief Financial Officer O'Hara John Charles | sold | $16K | SEC ↗ |
| 2026-05-15 | 5%+ holder (13G) Anson Funds Management LP | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-14 | Vice-President, Global Sales Buonanno Franck Jean | sold | $58K | SEC ↗ |
| 2026-05-06 | Vice President, R&DSS Enguent Jean-Pierre | sold | $47K | SEC ↗ |
| 2026-04-24 | Chief Financial Officer O'Hara John Charles | sold | $15K | SEC ↗ |
| 2026-04-23 | Chief Financial Officer O'Hara John Charles | sold | $29K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer O'Hara John Charles | sold | $31K | SEC ↗ |
| 2026-04-21 | Chief Financial Officer O'Hara John Charles | sold | $30K | SEC ↗ |
| 2026-04-20 | Chief Financial Officer O'Hara John Charles | sold | $28K | SEC ↗ |
| 2026-04-17 | Chief Financial Officer O'Hara John Charles | sold | $27K | SEC ↗ |
| 2026-04-16 | Chief Financial Officer O'Hara John Charles | sold | $27K | SEC ↗ |
| 2026-04-09 | Chief Financial Officer O'Hara John Charles | sold | $21K | SEC ↗ |